nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Lacrimation—Pentoxifylline—malaria	0.0165	0.0165	CcSEcCtD
Apraclonidine—Mydriasis—Quinidine—malaria	0.0135	0.0135	CcSEcCtD
Apraclonidine—Mydriasis—Quinine—malaria	0.0135	0.0135	CcSEcCtD
Apraclonidine—Vasodilation—Quinidine—malaria	0.0123	0.0123	CcSEcCtD
Apraclonidine—Vasodilation—Quinine—malaria	0.0123	0.0123	CcSEcCtD
Apraclonidine—Vasodilation procedure—Quinidine—malaria	0.0123	0.0123	CcSEcCtD
Apraclonidine—Vasodilation procedure—Quinine—malaria	0.0123	0.0123	CcSEcCtD
Apraclonidine—Mydriasis—Quinidine barbiturate—malaria	0.0122	0.0122	CcSEcCtD
Apraclonidine—Inflammation—Clindamycin—malaria	0.0113	0.0113	CcSEcCtD
Apraclonidine—Vasodilation—Quinidine barbiturate—malaria	0.0111	0.0111	CcSEcCtD
Apraclonidine—Vasodilation procedure—Quinidine barbiturate—malaria	0.0111	0.0111	CcSEcCtD
Apraclonidine—Dermatitis contact—Clindamycin—malaria	0.0109	0.0109	CcSEcCtD
Apraclonidine—Dermatitis contact—Quinidine—malaria	0.0107	0.0107	CcSEcCtD
Apraclonidine—Dermatitis contact—Quinine—malaria	0.0107	0.0107	CcSEcCtD
Apraclonidine—Lacrimation increased—Pentoxifylline—malaria	0.0106	0.0106	CcSEcCtD
Apraclonidine—Photophobia—Quinine—malaria	0.0101	0.0101	CcSEcCtD
Apraclonidine—Photophobia—Quinidine—malaria	0.0101	0.0101	CcSEcCtD
Apraclonidine—Mediastinal disorder—Proguanil—malaria	0.0101	0.0101	CcSEcCtD
Apraclonidine—Mental disorder—Proguanil—malaria	0.0098	0.0098	CcSEcCtD
Apraclonidine—Erythema—Proguanil—malaria	0.00974	0.00974	CcSEcCtD
Apraclonidine—Dermatitis contact—Quinidine barbiturate—malaria	0.00963	0.00963	CcSEcCtD
Apraclonidine—Photophobia—Quinidine barbiturate—malaria	0.00915	0.00915	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00823	0.00823	CcSEcCtD
Apraclonidine—Nervous system disorder—Proguanil—malaria	0.00779	0.00779	CcSEcCtD
Apraclonidine—Skin disorder—Proguanil—malaria	0.00772	0.00772	CcSEcCtD
Apraclonidine—Hypersensitivity—Pyrimethamine—malaria	0.00751	0.00751	CcSEcCtD
Apraclonidine—Nasopharyngitis—Dapsone—malaria	0.00739	0.00739	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Proguanil—malaria	0.00686	0.00686	CcSEcCtD
Apraclonidine—Asthma—Quinidine—malaria	0.00678	0.00678	CcSEcCtD
Apraclonidine—Asthma—Quinine—malaria	0.00678	0.00678	CcSEcCtD
Apraclonidine—Irritability—Quinidine barbiturate—malaria	0.00675	0.00675	CcSEcCtD
Apraclonidine—Abdominal discomfort—Clindamycin—malaria	0.00662	0.00662	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Proguanil—malaria	0.0065	0.0065	CcSEcCtD
Apraclonidine—Vomiting—Pyrimethamine—malaria	0.00648	0.00648	CcSEcCtD
Apraclonidine—Abdominal pain—Proguanil—malaria	0.00628	0.00628	CcSEcCtD
Apraclonidine—Asthma—Quinidine barbiturate—malaria	0.00611	0.00611	CcSEcCtD
Apraclonidine—Abdominal discomfort—Pentoxifylline—malaria	0.00585	0.00585	CcSEcCtD
Apraclonidine—Pharyngitis—Dapsone—malaria	0.00567	0.00567	CcSEcCtD
Apraclonidine—Bradycardia—Quinine—malaria	0.00552	0.00552	CcSEcCtD
Apraclonidine—Bradycardia—Quinidine—malaria	0.00552	0.00552	CcSEcCtD
Apraclonidine—Infestation NOS—Pentoxifylline—malaria	0.00544	0.00544	CcSEcCtD
Apraclonidine—Infestation—Pentoxifylline—malaria	0.00544	0.00544	CcSEcCtD
Apraclonidine—Diarrhoea—Proguanil—malaria	0.00544	0.00544	CcSEcCtD
Apraclonidine—Haemorrhage—Quinidine—malaria	0.00542	0.00542	CcSEcCtD
Apraclonidine—Haemorrhage—Quinine—malaria	0.00542	0.00542	CcSEcCtD
Apraclonidine—Conjunctivitis—Pentoxifylline—malaria	0.00529	0.00529	CcSEcCtD
Apraclonidine—Visual impairment—Quinidine—malaria	0.00523	0.00523	CcSEcCtD
Apraclonidine—Visual impairment—Quinine—malaria	0.00523	0.00523	CcSEcCtD
Apraclonidine—Eye disorder—Quinine—malaria	0.00507	0.00507	CcSEcCtD
Apraclonidine—Eye disorder—Quinidine—malaria	0.00507	0.00507	CcSEcCtD
Apraclonidine—Vomiting—Proguanil—malaria	0.00505	0.00505	CcSEcCtD
Apraclonidine—Dermatitis—Proguanil—malaria	0.00501	0.00501	CcSEcCtD
Apraclonidine—Bradycardia—Quinidine barbiturate—malaria	0.00498	0.00498	CcSEcCtD
Apraclonidine—Headache—Proguanil—malaria	0.00498	0.00498	CcSEcCtD
Apraclonidine—Erythema—Dapsone—malaria	0.00498	0.00498	CcSEcCtD
Apraclonidine—Haemorrhage—Quinidine barbiturate—malaria	0.00489	0.00489	CcSEcCtD
Apraclonidine—Mediastinal disorder—Quinidine—malaria	0.00489	0.00489	CcSEcCtD
Apraclonidine—Mediastinal disorder—Quinine—malaria	0.00489	0.00489	CcSEcCtD
Apraclonidine—Haemorrhage—Pentoxifylline—malaria	0.00489	0.00489	CcSEcCtD
Apraclonidine—Erythema—Clindamycin—malaria	0.00481	0.00481	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00481	0.00481	CcSEcCtD
Apraclonidine—Insomnia—Sulfadiazine—malaria	0.00477	0.00477	CcSEcCtD
Apraclonidine—Mental disorder—Quinine—malaria	0.00475	0.00475	CcSEcCtD
Apraclonidine—Mental disorder—Quinidine—malaria	0.00475	0.00475	CcSEcCtD
Apraclonidine—Erythema—Quinine—malaria	0.00472	0.00472	CcSEcCtD
Apraclonidine—Erythema—Quinidine—malaria	0.00472	0.00472	CcSEcCtD
Apraclonidine—Nausea—Proguanil—malaria	0.00472	0.00472	CcSEcCtD
Apraclonidine—Visual impairment—Quinidine barbiturate—malaria	0.00472	0.00472	CcSEcCtD
Apraclonidine—Dysgeusia—Clindamycin—malaria	0.00471	0.00471	CcSEcCtD
Apraclonidine—Vision blurred—Dapsone—malaria	0.00469	0.00469	CcSEcCtD
Apraclonidine—Eye disorder—Quinidine barbiturate—malaria	0.00457	0.00457	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Sulfadiazine—malaria	0.00455	0.00455	CcSEcCtD
Apraclonidine—Vision blurred—Quinine—malaria	0.00445	0.00445	CcSEcCtD
Apraclonidine—Vision blurred—Quinidine—malaria	0.00445	0.00445	CcSEcCtD
Apraclonidine—Mediastinal disorder—Quinidine barbiturate—malaria	0.00441	0.00441	CcSEcCtD
Apraclonidine—Arrhythmia—Pentoxifylline—malaria	0.00436	0.00436	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Sulfadiazine—malaria	0.00431	0.00431	CcSEcCtD
Apraclonidine—Mental disorder—Quinidine barbiturate—malaria	0.00429	0.00429	CcSEcCtD
Apraclonidine—Erythema—Quinidine barbiturate—malaria	0.00426	0.00426	CcSEcCtD
Apraclonidine—Erythema—Pentoxifylline—malaria	0.00425	0.00425	CcSEcCtD
Apraclonidine—Syncope—Quinidine—malaria	0.00423	0.00423	CcSEcCtD
Apraclonidine—Syncope—Quinine—malaria	0.00423	0.00423	CcSEcCtD
Apraclonidine—Tension—Quinidine barbiturate—malaria	0.00418	0.00418	CcSEcCtD
Apraclonidine—Tension—Pentoxifylline—malaria	0.00417	0.00417	CcSEcCtD
Apraclonidine—Palpitations—Quinine—malaria	0.00417	0.00417	CcSEcCtD
Apraclonidine—Palpitations—Quinidine—malaria	0.00417	0.00417	CcSEcCtD
Apraclonidine—Abdominal pain—Sulfadiazine—malaria	0.00417	0.00417	CcSEcCtD
Apraclonidine—Dysgeusia—Pentoxifylline—malaria	0.00416	0.00416	CcSEcCtD
Apraclonidine—Nervousness—Quinidine barbiturate—malaria	0.00414	0.00414	CcSEcCtD
Apraclonidine—Nervousness—Pentoxifylline—malaria	0.00413	0.00413	CcSEcCtD
Apraclonidine—Discomfort—Clindamycin—malaria	0.00405	0.00405	CcSEcCtD
Apraclonidine—Chest pain—Quinine—malaria	0.00402	0.00402	CcSEcCtD
Apraclonidine—Myalgia—Quinine—malaria	0.00402	0.00402	CcSEcCtD
Apraclonidine—Myalgia—Quinidine—malaria	0.00402	0.00402	CcSEcCtD
Apraclonidine—Chest pain—Quinidine—malaria	0.00402	0.00402	CcSEcCtD
Apraclonidine—Vision blurred—Quinidine barbiturate—malaria	0.00402	0.00402	CcSEcCtD
Apraclonidine—Vision blurred—Pentoxifylline—malaria	0.00401	0.00401	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00399	0.00399	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00399	0.00399	CcSEcCtD
Apraclonidine—Ill-defined disorder—Pentoxifylline—malaria	0.00395	0.00395	CcSEcCtD
Apraclonidine—Hypersensitivity—Sulfadiazine—malaria	0.00389	0.00389	CcSEcCtD
Apraclonidine—Oedema—Quinine—malaria	0.00385	0.00385	CcSEcCtD
Apraclonidine—Oedema—Quinidine—malaria	0.00385	0.00385	CcSEcCtD
Apraclonidine—Malaise—Pentoxifylline—malaria	0.00384	0.00384	CcSEcCtD
Apraclonidine—Syncope—Quinidine barbiturate—malaria	0.00382	0.00382	CcSEcCtD
Apraclonidine—Nervous system disorder—Quinine—malaria	0.00378	0.00378	CcSEcCtD
Apraclonidine—Nervous system disorder—Quinidine—malaria	0.00378	0.00378	CcSEcCtD
Apraclonidine—Palpitations—Quinidine barbiturate—malaria	0.00377	0.00377	CcSEcCtD
Apraclonidine—Palpitations—Pentoxifylline—malaria	0.00376	0.00376	CcSEcCtD
Apraclonidine—Skin disorder—Quinine—malaria	0.00374	0.00374	CcSEcCtD
Apraclonidine—Skin disorder—Quinidine—malaria	0.00374	0.00374	CcSEcCtD
Apraclonidine—Pruritus—Sulfadiazine—malaria	0.00373	0.00373	CcSEcCtD
Apraclonidine—Insomnia—Dapsone—malaria	0.00367	0.00367	CcSEcCtD
Apraclonidine—Myalgia—Quinidine barbiturate—malaria	0.00363	0.00363	CcSEcCtD
Apraclonidine—Chest pain—Quinidine barbiturate—malaria	0.00363	0.00363	CcSEcCtD
Apraclonidine—Chest pain—Pentoxifylline—malaria	0.00362	0.00362	CcSEcCtD
Apraclonidine—Myalgia—Pentoxifylline—malaria	0.00362	0.00362	CcSEcCtD
Apraclonidine—Diarrhoea—Sulfadiazine—malaria	0.00361	0.00361	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.0036	0.0036	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.0036	0.0036	CcSEcCtD
Apraclonidine—Discomfort—Pentoxifylline—malaria	0.00358	0.00358	CcSEcCtD
Apraclonidine—Dry mouth—Pentoxifylline—malaria	0.00354	0.00354	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Quinidine—malaria	0.00351	0.00351	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Quinine—malaria	0.00351	0.00351	CcSEcCtD
Apraclonidine—Dyspnoea—Clindamycin—malaria	0.0035	0.0035	CcSEcCtD
Apraclonidine—Oedema—Quinidine barbiturate—malaria	0.00348	0.00348	CcSEcCtD
Apraclonidine—Oedema—Pentoxifylline—malaria	0.00347	0.00347	CcSEcCtD
Apraclonidine—Infection—Pentoxifylline—malaria	0.00345	0.00345	CcSEcCtD
Apraclonidine—Dyspnoea—Quinidine—malaria	0.00344	0.00344	CcSEcCtD
Apraclonidine—Dyspnoea—Quinine—malaria	0.00344	0.00344	CcSEcCtD
Apraclonidine—Nervous system disorder—Quinidine barbiturate—malaria	0.00341	0.00341	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Clindamycin—malaria	0.00339	0.00339	CcSEcCtD
Apraclonidine—Fatigue—Clindamycin—malaria	0.00339	0.00339	CcSEcCtD
Apraclonidine—Skin disorder—Quinidine barbiturate—malaria	0.00338	0.00338	CcSEcCtD
Apraclonidine—Skin disorder—Pentoxifylline—malaria	0.00337	0.00337	CcSEcCtD
Apraclonidine—Pain—Clindamycin—malaria	0.00336	0.00336	CcSEcCtD
Apraclonidine—Constipation—Clindamycin—malaria	0.00336	0.00336	CcSEcCtD
Apraclonidine—Vomiting—Sulfadiazine—malaria	0.00335	0.00335	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Quinine—malaria	0.00333	0.00333	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Quinidine—malaria	0.00333	0.00333	CcSEcCtD
Apraclonidine—Dermatitis—Sulfadiazine—malaria	0.00332	0.00332	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dapsone—malaria	0.00332	0.00332	CcSEcCtD
Apraclonidine—Headache—Sulfadiazine—malaria	0.0033	0.0033	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Clindamycin—malaria	0.00321	0.00321	CcSEcCtD
Apraclonidine—Abdominal pain—Dapsone—malaria	0.00321	0.00321	CcSEcCtD
Apraclonidine—Feeling abnormal—Quinidine—malaria	0.00318	0.00318	CcSEcCtD
Apraclonidine—Feeling abnormal—Quinine—malaria	0.00318	0.00318	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00317	0.00317	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00316	0.00316	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Quinidine—malaria	0.00315	0.00315	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Quinine—malaria	0.00315	0.00315	CcSEcCtD
Apraclonidine—Insomnia—Pentoxifylline—malaria	0.00314	0.00314	CcSEcCtD
Apraclonidine—Nausea—Sulfadiazine—malaria	0.00313	0.00313	CcSEcCtD
Apraclonidine—Abdominal pain—Clindamycin—malaria	0.0031	0.0031	CcSEcCtD
Apraclonidine—Dyspnoea—Quinidine barbiturate—malaria	0.0031	0.0031	CcSEcCtD
Apraclonidine—Dyspnoea—Pentoxifylline—malaria	0.00309	0.00309	CcSEcCtD
Apraclonidine—Somnolence—Quinidine barbiturate—malaria	0.00309	0.00309	CcSEcCtD
Apraclonidine—Somnolence—Pentoxifylline—malaria	0.00309	0.00309	CcSEcCtD
Apraclonidine—Abdominal pain—Quinine—malaria	0.00305	0.00305	CcSEcCtD
Apraclonidine—Abdominal pain—Quinidine—malaria	0.00305	0.00305	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.003	0.003	CcSEcCtD
Apraclonidine—Constipation—Quinidine barbiturate—malaria	0.00297	0.00297	CcSEcCtD
Apraclonidine—Pain—Quinidine barbiturate—malaria	0.00297	0.00297	CcSEcCtD
Apraclonidine—Constipation—Pentoxifylline—malaria	0.00297	0.00297	CcSEcCtD
Apraclonidine—Hypersensitivity—Clindamycin—malaria	0.00289	0.00289	CcSEcCtD
Apraclonidine—Feeling abnormal—Quinidine barbiturate—malaria	0.00287	0.00287	CcSEcCtD
Apraclonidine—Feeling abnormal—Pentoxifylline—malaria	0.00286	0.00286	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00284	0.00284	CcSEcCtD
Apraclonidine—Hypersensitivity—Quinidine—malaria	0.00284	0.00284	CcSEcCtD
Apraclonidine—Hypersensitivity—Quinine—malaria	0.00284	0.00284	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Pentoxifylline—malaria	0.00284	0.00284	CcSEcCtD
Apraclonidine—Asthenia—Clindamycin—malaria	0.00282	0.00282	CcSEcCtD
Apraclonidine—Pruritus—Clindamycin—malaria	0.00278	0.00278	CcSEcCtD
Apraclonidine—Asthenia—Quinine—malaria	0.00276	0.00276	CcSEcCtD
Apraclonidine—Asthenia—Quinidine—malaria	0.00276	0.00276	CcSEcCtD
Apraclonidine—Abdominal pain—Quinidine barbiturate—malaria	0.00275	0.00275	CcSEcCtD
Apraclonidine—Abdominal pain—Pentoxifylline—malaria	0.00274	0.00274	CcSEcCtD
Apraclonidine—Pruritus—Quinine—malaria	0.00273	0.00273	CcSEcCtD
Apraclonidine—Pruritus—Quinidine—malaria	0.00273	0.00273	CcSEcCtD
Apraclonidine—Diarrhoea—Clindamycin—malaria	0.00269	0.00269	CcSEcCtD
Apraclonidine—Diarrhoea—Quinidine—malaria	0.00264	0.00264	CcSEcCtD
Apraclonidine—Diarrhoea—Quinine—malaria	0.00264	0.00264	CcSEcCtD
Apraclonidine—Dizziness—Clindamycin—malaria	0.0026	0.0026	CcSEcCtD
Apraclonidine—Vomiting—Dapsone—malaria	0.00258	0.00258	CcSEcCtD
Apraclonidine—Hypersensitivity—Quinidine barbiturate—malaria	0.00256	0.00256	CcSEcCtD
Apraclonidine—Hypersensitivity—Pentoxifylline—malaria	0.00256	0.00256	CcSEcCtD
Apraclonidine—Dizziness—Quinine—malaria	0.00255	0.00255	CcSEcCtD
Apraclonidine—Dizziness—Quinidine—malaria	0.00255	0.00255	CcSEcCtD
Apraclonidine—Headache—Dapsone—malaria	0.00254	0.00254	CcSEcCtD
Apraclonidine—Vomiting—Clindamycin—malaria	0.0025	0.0025	CcSEcCtD
Apraclonidine—Asthenia—Quinidine barbiturate—malaria	0.00249	0.00249	CcSEcCtD
Apraclonidine—Asthenia—Pentoxifylline—malaria	0.00249	0.00249	CcSEcCtD
Apraclonidine—Dermatitis—Clindamycin—malaria	0.00247	0.00247	CcSEcCtD
Apraclonidine—Headache—Clindamycin—malaria	0.00246	0.00246	CcSEcCtD
Apraclonidine—Pruritus—Quinidine barbiturate—malaria	0.00246	0.00246	CcSEcCtD
Apraclonidine—Pruritus—Pentoxifylline—malaria	0.00246	0.00246	CcSEcCtD
Apraclonidine—Vomiting—Quinine—malaria	0.00245	0.00245	CcSEcCtD
Apraclonidine—Vomiting—Quinidine—malaria	0.00245	0.00245	CcSEcCtD
Apraclonidine—Dermatitis—Quinine—malaria	0.00243	0.00243	CcSEcCtD
Apraclonidine—Dermatitis—Quinidine—malaria	0.00243	0.00243	CcSEcCtD
Apraclonidine—Headache—Quinine—malaria	0.00241	0.00241	CcSEcCtD
Apraclonidine—Headache—Quinidine—malaria	0.00241	0.00241	CcSEcCtD
Apraclonidine—Nausea—Dapsone—malaria	0.00241	0.00241	CcSEcCtD
Apraclonidine—Diarrhoea—Quinidine barbiturate—malaria	0.00238	0.00238	CcSEcCtD
Apraclonidine—Diarrhoea—Pentoxifylline—malaria	0.00237	0.00237	CcSEcCtD
Apraclonidine—Nausea—Clindamycin—malaria	0.00233	0.00233	CcSEcCtD
Apraclonidine—Dizziness—Quinidine barbiturate—malaria	0.0023	0.0023	CcSEcCtD
Apraclonidine—Dizziness—Pentoxifylline—malaria	0.0023	0.0023	CcSEcCtD
Apraclonidine—Nausea—Quinidine—malaria	0.00229	0.00229	CcSEcCtD
Apraclonidine—Nausea—Quinine—malaria	0.00229	0.00229	CcSEcCtD
Apraclonidine—Vomiting—Quinidine barbiturate—malaria	0.00221	0.00221	CcSEcCtD
Apraclonidine—Vomiting—Pentoxifylline—malaria	0.00221	0.00221	CcSEcCtD
Apraclonidine—Dermatitis—Quinidine barbiturate—malaria	0.00219	0.00219	CcSEcCtD
Apraclonidine—Dermatitis—Pentoxifylline—malaria	0.00219	0.00219	CcSEcCtD
Apraclonidine—Headache—Quinidine barbiturate—malaria	0.00218	0.00218	CcSEcCtD
Apraclonidine—Headache—Pentoxifylline—malaria	0.00217	0.00217	CcSEcCtD
Apraclonidine—Nausea—Quinidine barbiturate—malaria	0.00207	0.00207	CcSEcCtD
Apraclonidine—Nausea—Pentoxifylline—malaria	0.00206	0.00206	CcSEcCtD
